Clinical Trial Update: Ranolazine Cardioprotection in PCI [Phase 2]

View source ↗

Summary

Phase 2 trial of ranolazine for cardioprotection in PCI terminated; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Harvey Hahn | Conditions: Acute Coronary Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2015-11-20